What we have achieved

2000Volunteers recruited
250Completed trials since 1996
70Investigator Initiated Trials completed
180Industry Sponsored Trials completed

Ongoing clinical trials in IMU

Phase 3 Anemia Study in CKD to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa (ASCEND-ND)

A phase 3 randomized, open-label (sponsor-blind), activecontrolled, parallel-group, multi-center, event driven study in non-dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Anemia Studies in CKD: Erythropoiesis via a Novel PHI Daprodustat-Non-Dialysis (ASCEND-ND)

Medical device study on treatment of Benign Prostatic Hyperplasia using ProstaCare Water Electrolysis System

ProstaCare Water Electrolysis System for the Treatment of Benign Prostatic Hyperplasia

Phase 3 Venous Thromboembolism study to evaluate the efficacy and safety of an age and body weight adjusted rivaroxaban regimen

Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age and body weight adjusted rivaroxaban regimen compared to the standard of care in children with acute venous thromboembolism (Bayer Einstein Junior)

Volunteers

Be a hero to others today!

Be part of a journey to discover new therapies to improve the future of healthcare.

Partners

Interested to work together with us?

Collaborate with IMU to discover better treatments for a better tomorrow.